Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated ...

Serena Williams, the tennis icon, has revealed her postpartum weight loss journey, shedding 31 pounds with the help of GLP-1 ...

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.

Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...

Tennis champion Serena Williams said Thursday that she is taking weight loss medication after struggling to see results from diet and exercise following the birth of her two daughters, Olympia and ...

Sales of the weight loss injection Wegovy have skyrocketed in the UK after the manufacturer of rival drug Mounjaro announced ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication ...

(Reuters) -Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss ...

As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.